LEON O JR MOULDER
CIK 1228865 · See Remarks · last filed 2026-06-22
LEON O JR MOULDER is a corporate insider who has filed 60 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for ZLAB, was dated Jun 22, 2026. Across all open-market trades the lifetime net is +$7.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $172.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$172.22M
8
60
$7.79M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZLAB | Director | 94,973 | $25.30 | $2.40M | $0 | 6 | 2026-06-22 |
| ZBIO | See Remarks | 520,083 | $31.98 | $16.63M | $6.91M | 13 | 2026-06-17 |
| DNTH | Director | 1,436,745 | $106.62 | $153.19M | $0 | 3 | 2024-05-28 |
| TREVENA INC (TRVN) Delisted | Director | 240 | $0.01 | $3 | $302.0K | 11 | 2023-06-20 |
| TESARO, Inc. (TSRO) Delisted | Chief Executive Officer | 0 | — | — | $401.5K | 11 | 2019-01-22 |
| CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted | Director | 0 | — | — | $0 | 1 | 2015-01-21 |
| CUBIST PHARMACEUTICALS INC (CBST) Delisted | Director | 9,098 | — | — | $183.9K | 7 | 2013-06-14 |
| MGI PHARMA INC (MOGN) Delisted | President & CEO | 17,500 | — | — | $0 | 6 | 2008-01-25 |
Recent Filings
60 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-22 | ZLAB | Grant (A) | +22,371 | $0 | EDGAR |
| 2026-06-17 | ZBIO | Grant (A) | — | $0 | EDGAR |
| 2026-05-18 | ZBIO | Buy (P) | +60,000 | $1.01M | EDGAR |
| 2026-04-29 | ZBIO | Buy (P) | +60,000 | $1.07M | EDGAR |
| 2026-02-03 | ZBIO | Buy (P) | +57,000 | $1.02M | EDGAR |
| 2026-01-09 | ZBIO | Buy (P) | +100,000 | $1.64M | EDGAR |
| 2025-10-09 | ZBIO | Buy (P) | +36,928 | $769.9K | EDGAR |
| 2025-06-23 | ZLAB | Grant (A) | +10,831 | $0 | EDGAR |
| 2025-06-12 | ZBIO | Grant (A) | — | $0 | EDGAR |
| 2025-02-19 | ZBIO | Buy (P) | +25,000 | $166.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.